Kovitz Investment Group Partners’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.11M | Sell |
113,939
-5,822
| -5% | -$210K | 0.02% | 480 |
|
|
2025
Q1 | $3.73M | Sell |
119,761
-7,573
| -6% | -$236K | 0.02% | 456 |
|
|
2024
Q4 | $3.25M | Buy |
127,334
+8,580
| +7% | +$219K | 0.02% | 484 |
|
|
2024
Q3 | $3.34M | Sell |
118,754
-50,665
| -30% | -$1.42M | 0.02% | 407 |
|
|
2024
Q2 | $4.47M | Buy |
169,419
+61,661
| +57% | +$1.63M | 0.04% | 302 |
|
|
2024
Q1 | $3.27M | Buy |
107,758
+23,712
| +28% | +$720K | 0.04% | 249 |
|
|
2023
Q4 | $2.36M | Sell |
84,046
-16,620
| -17% | -$467K | 0.04% | 225 |
|
|
2023
Q3 | $2.73M | Buy |
100,666
+34,559
| +52% | +$938K | 0.05% | 204 |
|
|
2023
Q2 | $2.03M | Sell |
66,107
-7,725
| -10% | -$237K | 0.03% | 238 |
|
|
2023
Q1 | $2.66M | Sell |
73,832
-3,810
| -5% | -$137K | 0.05% | 218 |
|
|
2022
Q4 | $3.07M | Sell |
77,642
-5,521
| -7% | -$218K | 0.06% | 201 |
|
|
2022
Q3 | $3.34M | Sell |
83,163
-6,435
| -7% | -$259K | 0.08% | 185 |
|
|
2022
Q2 | $3.77M | Sell |
89,598
-29,701
| -25% | -$1.25M | 0.08% | 186 |
|
|
2022
Q1 | $4.65M | Buy |
119,299
+60,994
| +105% | +$2.38M | 0.09% | 172 |
|
|
2021
Q4 | $2.92M | Sell |
58,305
-71,692
| -55% | -$3.59M | 0.07% | 175 |
|
|
2021
Q3 | $4.7M | Buy |
129,997
+33,140
| +34% | +$1.2M | 0.09% | 150 |
|
|
2021
Q2 | $3.97M | Buy |
96,857
+38,364
| +66% | +$1.57M | 0.08% | 174 |
|
|
2021
Q1 | $2.55M | Buy |
58,493
+313
| +0.5% | +$13.7K | 0.06% | 198 |
|
|
2020
Q4 | $2.91M | Buy |
58,180
+34,095
| +142% | +$1.71M | 0.07% | 172 |
|
|
2020
Q3 | $1.01M | Buy |
+24,085
| New | +$1.01M | 0.03% | 253 |
|